Global Oncology Market Research Report 2021 Overview, Territorial Outlook, Technology, Demand and Estimate 2027
With the prevalence of growing cancer and rising awareness regarding cancer detection at early stages, global Oncology Market is set to witness exponential growth over the forthcoming years. According to a report by Global Market Insights, Inc., oncology market is projected to observe a remarkable CAGR of 10.1% through 2026 and is expected to surpass a valuation of USD 469.5 billion over 2020 to 2026.
The growth can also be credited to ongoing
technological advancements in oncology treatment and management. Industry
players such as Janssen Diagnostics, GE Healthcare, F. Hoffmann-La Roche,
Merck, Abbott, Pfizer, Thermo Fischer Scientific, Bayer AG, etc. are focusing
on developing innovative product offerings for effectively serving the consumer
demand and gaining a strong market presence worldwide. For instance, in 2019,
GE healthcare announced its commercial partnership with Theragnostics for
developing a new Prostate-Specific Membrane Antigen (PSMA) imaging solution.
According to the agreement, Theragnostics will develop the tracer, GalliProst,
while GE Healthcare will look after the pre-approval commercial preparations as
well as distribution activities post the approval.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/4879
This apart, rising initiatives by the government
and non-government organizations for reducing the burden of cancer, is also
anticipated to have a positive influence on the industry growth. For instance,
in 2013, the World Health Organization launched the Global Action Plan for the
Prevention and Control of Non-communicable Diseases 2013-2020. Reportedly, the
plan was aimed at reducing 25% of premature deaths from cardiovascular
diseases, diabetes, chronic respiratory diseases and cancer by 2025.
An
overview of the prominent segments that are likely to transform oncology market
outlook is mentioned below:
With
regards to cancer diagnostics & cancer treatment, cancer diagnostics
segment recorded a substantial valuation of USD 104.9 billion in 2019 and is
likely to grow over time. This can be credited to rising incidences of cancer
along with several applications of cancer diagnosis for the detection of
different types of cancer. Speaking of the cancer incidences, the National
Cancer Institute has reported that in 2017, the rate of new cases of cancer was
442.4 per 100,000 men and women. Besides, the availability of technologically
advanced cancer detection techniques across hospitals and diagnostics lab will
enhance the segment outlook over the foreseeable future.
Based on
cancer type, prostate cancer is estimated to record a valuation of USD 47.9
billion by 2026 considering a prolific surge in the prevalence of prostate
cancer worldwide. According to a report by the Global Cancer Observatory
(GLOBOCAN), around 12.7 million new cases of prostate cancer were recorded
across the globe in 2018. Also, as per the American Society of Clinical
Oncology, in 2017, prostate cancer emerged as the second major cause of death
related to cancer among men in the U.S., resulting in 33,330 deaths. Besides,
the report has also estimated that in 2020, around 191,930 men in the U.S. are
likely to be diagnosed with prostate cancer.
Request
for customization @ https://www.gminsights.com/roc/4879
In terms
of end-use, the diagnostic imaging centers segment recorded an appreciable
valuation of USD 17.6 billion in 2019 and is expected to observe substantial
growth over the upcoming years. This can be attributed to the availability of
technologically enhanced diagnostic equipment. In this regard, the imaging
technique has emerged as a crucial technology being extensively adopted by
these centers as they play a key role in the diagnosis of almost every type of
cancer. In addition, factors such as growing geriatric population and rising
awareness regarding early diagnosis of cancer disease are likely to foster the
segment growth further.
In terms
of regional outlook, Asia Pacific oncology market is projected to observe a
significant CAGR of 11.4% through 2026 owing to growing awareness regarding
early detection and mitigation of cancer in the region. Moreover, the
availability of large patient pool across highly populous countries that are
susceptible to several types of cancer will instigate the demand for oncology
treatment further. For instance, China has reported second highest number of
cancer cases following the U.S. Reportedly, in 2018, China accounted for 19.9
million new cases of cancer in females.
Browse key industry insights spread
across 246 pages with 254 market data tables and 29 figures & charts from
the report, Oncology Market in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/oncology-market
Report Content
Chapter 3 Global
Oncology Industry Insights
3.1 Industry
segmentation
3.2 Industry landscape,
2015 - 2026
3.3 Industry impact
forces
3.3.1 Growth drivers
3.3.1.1 Rising
incidence of cancer globally
3.3.1.2 Several
initiatives undertaken by government and other organizations to spread disease
awareness
3.3.1.3 Growing number
of diagnostic laboratories in developing countries
3.3.1.4 Technological
advancements in developed countries
3.3.2 Industry
pitfalls & challenges
3.3.2.1 High capital
investment coupled with high cost associated with diagnostic imaging system
3.3.2.2 High risk of
side effects associated with cancer treatment
3.3.2.3 Risk related
with high radiation exposure affecting use of CT scanners
3.4 Growth potential
analysis
3.4.1 By cancer
diagnostics & treatment
3.4.2 By cancer type
3.4.3 By end-use
3.5 COVID-19 impact
analysis
3.6 Porter's analysis
3.7 Competitive
landscape, 2019
3.7.1 Company matrix
analysis
About Global Market Insights
Global Market Insights,
Inc., headquartered in Delaware, U.S., is a global market research and
consulting service provider; offering syndicated and custom research reports
along with growth consulting services. Our business intelligence and industry
research reports offer clients with penetrative insights and actionable market
data specially designed and presented to aid strategic decision making. These
exhaustive reports are designed via a proprietary research methodology and are
available for key industries such as chemicals, advanced materials, technology,
renewable energy and biotechnology.
Contact Us:
Arun
Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Comments
Post a Comment